Skip to content

A Natural Approach to Managing Dandruff

A Randomized Controlled Clinical Study to Evaluate the Safety and Efficacy of a Topical Unani Formulation in the Management of Huzaz (Dandruff) - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/109826
Enrollment
60
Registered
2026-04-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue

Interventions

Intervention1: Topical Polyherbal Unani formulation 25 ml of shampoo is to be applied on scalp thrice a week for 4 weeks.: Topical Polyherbal Unani formulation consists of following constituents: 1) N

Sponsors

Jamia Hamdard University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients who are willing to give written informed consent. 2) Clinically stable patients of Dandruff including: i.Scaling over scalp ii. Pruritis on scalp iii. Erythema on scalp

Exclusion criteria

Exclusion criteria: 1)Pregnant and lactating women. 2) Unwillingly to participate in the study. 3) Patient with psoriasis, tinea capitis or folliculitis, contact dermatitis, alopecia aerata. 4) Patients suffering from disease of scalp other than dandruff. 5)Patient using topical household/ ayurvedic remedies. 6) History of surgery on scalp. 7) Patient suffering from major systemic disease 8) Pts with Chronic liver, kidney or heart disease, carcinoma or any other terminal illness. 9) Patient with hypersensitivity, immunodeficiency and known drug allergies/ history of allergic response to any hair care products. 10)Patients who are not willing to discontinue hair treatments like perming/ coloring, oiling, hair masks etc. 11) Use of anti-inflammatory drugs, steroids and antifungal medications (a washout period is required for inclusion in the study) 12) Patients using ketoconazole (a washout period of 2 weeks for ketoconazole and selenium sulfide lotions is required for inclusion in the study).

Design outcomes

Primary

MeasureTime frame
To evaluate the safety and efficacy of shampoo-based Unani formulation in the management of Huzaz (dandruff)Timepoint: 0 day, 7th Day, 14th Day, 28th day and 42nd Day

Secondary

MeasureTime frame
To assess the improvement in the quality of life in the patients of Huzaz after treatmentTimepoint: At Baseline & 28th Day

Countries

India

Contacts

Public ContactDr Mumtaz Khan

Jamia Hamdard

shaziajilani@jamiahamdard.ac.in9718764154

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026